Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041261 · ClinicalTrials.gov registry record · NA
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
A NA study, sponsored by MetaProteomics.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01041261: Clinical Trial NA study, sponsored by MetaProteomics.
NCT01041261 is a NA study that was terminated before completion, run by MetaProteomics. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01041261, a NA study, was terminated before completion, sponsored by MetaProteomics.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
We propose to compare the standard of care with the use of a novel medical food in 6 bariatric surgery patients by measuring outcomes of body composition, quality of life, hair loss, muscle strength, resting energy expenditure, and biochemical parameters.
Interventions
- DIETARY_SUPPLEMENT BariatrX Essentials 360 Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Why NCT01041261 stopped before completion
NCT01041261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which BariatrX Essentials 360 Treatment is the first listed.
NCT01041261 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01041261 about?
NCT01041261 is a clinical study titled "Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery". We propose to compare the standard of care with the use of a novel medical food in 6 bariatric surgery patients by measuring outcomes of body composition, quality of life, hair loss, muscle strength, resting energy expenditure, and biochemical parameters.
What is the current status of trial NCT01041261?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2009-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01041261?
The interventions under investigation include: BariatrX Essentials 360 Treatment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01041261?
This trial is sponsored by MetaProteomics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01041261's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia